First In-Human Experience With Complete Integration of Neuromodulation Device Within a Customized Cranial Implant

2017 ◽  
Vol 15 (1) ◽  
pp. 39-45 ◽  
Author(s):  
Chad R Gordon ◽  
Gabriel F Santiago ◽  
Judy Huang ◽  
Gregory K Bergey ◽  
Shuya Liu ◽  
...  

Abstract BACKGROUND Neuromodulation devices have the potential to transform modern day treatments for patients with medicine-resistant neurological disease. For instance, the NeuroPace System (NeuroPace Inc, Mountain View, California) is a Food and Drug Administration (FDA)-approved device developed for closed-loop direct brain neurostimulation in the setting of drug-resistant focal epilepsy. However, current methods require placement either above or below the skull in nonanatomic locations. This type of positioning has several drawbacks including visible deformities and scalp pressure from underneath leading to eventual wound healing difficulties, micromotion of hardware with infection, and extrusion leading to premature explantation. OBJECTIVE To introduce complete integration of a neuromodulation device within a customized cranial implant for biocompatibility optimization and prevention of visible deformity. METHODS We report a patient with drug-resistant focal epilepsy despite previous seizure surgery and maximized medical therapy. Preoperative imaging demonstrated severe resorption of previous bone flap causing deformity and risk for injury. She underwent successful responsive neurostimulation device implantation via complete integration within a clear customized cranial implant. RESULTS The patient has recovered well without complication and has been followed closely for 180 d. Device interrogation with electrocorticographic data transmission has been successfully performed through the clear implant material for the first time with no evidence of any wireless transmission interference. CONCLUSION Cranial contour irregularities, implant site infection, and bone flap resorption/osteomyelitis are adverse events associated with implantable neurotechnology. This method represents a novel strategy to incorporate all future neuromodulation devices within the confines of a low-profile, computer-designed cranial implant and the newfound potential to eliminate contour irregularities, improve outcomes, and optimize patient satisfaction.

2021 ◽  
Vol 2021 (6) ◽  
Author(s):  
Xian-Chao Chang ◽  
Hai Yuan ◽  
Yi Wang ◽  
Hui-Qin Xu ◽  
Wen-Ke Hong ◽  
...  

2021 ◽  
Vol 2021 (7) ◽  
Author(s):  
Myrsini Gianatsi ◽  
Rebecca Bresnahan ◽  
Ruaraidh A Hill ◽  
Sarah J Nevitt ◽  
Anthony G Marson ◽  
...  

2021 ◽  
Vol 31 (4) ◽  
Author(s):  
Katja Kobow ◽  
Stéphanie Baulac ◽  
Andreas Deimling ◽  
Jeong Ho Lee

Author(s):  
Mariangela Panebianco ◽  
Sarah Al-Bachari ◽  
Jane L Hutton ◽  
Anthony G Marson

2018 ◽  
Vol 9 (1) ◽  
pp. 61 ◽  
Author(s):  
SabrinaA de França ◽  
ThalesB Nepomuceno ◽  
WellingsonS Paiva ◽  
AlmirF Andrade ◽  
ManoelJ Teixeira ◽  
...  

Epilepsia ◽  
2019 ◽  
Vol 60 (8) ◽  
Author(s):  
Francesca Conte ◽  
Wim Van Paesschen ◽  
Benjamin Legros ◽  
Chantal Depondt

Sign in / Sign up

Export Citation Format

Share Document